Changes in cervical movement impairment and pain following orofacial treatment in patients with chronic arthralgic temporomandibular disorder with pain: A prospective case series

The purpose of this study was to investigate the influence of isolated temporomandibular joint (TMJ) manual therapy on pain and range of motion (ROM) of the TMJ and cervical spine including flexion-rotation test (FRT) in people suffering chronic pain arising from chronic arthralgic temporomandibular disorder (TMD). An experienced clinician managed a case series of 12 patients with TMD (mean duration 28.6 months +/- 26.9). The intervention comprised four-weekly sessions of transverse medial accessory TMJ mobilization and advice. Patients were examined prior to and one-week following the intervention period. Outcome measures included jaw disability (JFLS-20), jaw pain measured by Visual Analogue Scale (VAS), maximal mouth opening ROM, cervical ROM including FRT, and pain during cervical movement. A paired t-test revealed significant improvement following the intervention in disability (p < 0.001), VAS pain score at rest (p < 0.001) and at maximum mouth opening (p < 0.001), jaw opening ROM (p < 0.001), FRT ROM to the left (p = 0.024) and right (p = 0.001). In contrast, no significant change was identified for total cervical ROM (p = 0.905). After the intervention, five patients (41.66%) had no pain at rest or at maximal mouth opening, and all had a negative FRT. The effect sizes indicate a moderate to strong, clinically significant effect for all variables apart from total cervical ROM. While a case series cannot identify a cause and effect relationship, these results provide preliminary evidence for the influence of TMJ manual therapy on measures of TMD including pain, as well as upper but not whole cervical movement and associated pain in patients with a diagnosis of TMJ arthralgia

The Effects of Huntingtin-Lowering: What Do We Know So Far?

Therapies targeting mutant huntingtin DNA, mRNA, and protein have a chance at becoming the first disease-modifying treatments for Huntington’s disease, a fatal inherited neurodegenerative disorder for which only symptom management treatments are available today. This review focuses on evidence addressing several key questions pertinent to huntingtin-lowering, ranging from the functions of wild-type huntingtin (wtHTT) that may be disrupted by huntingtin-lowering treatments through the various ways huntingtin can be lowered, the tolerability of wtHTT-lowering in mice and primates, what has been found in the Ionis Pharmaceutical safety trial of a huntingtin-lowering therapy, and to the question of how much mutant huntingtin may need to be lowered for a therapy to be clinically effective. We conclude that adverse consequences of lowering wtHTT in animals appear to be brain region-specific, and/or dependent upon the animal’s stage of development and the amount by which huntingtin is lowered. Therefore, safe approaches to huntingtin-lowering in patients may be to lower huntingtin only moderately, or lower huntingtin only in the most affected brain regions, or lower huntingtin allele-selectively, or all of the above. Many additional questions about huntingtin-lowering remain open, and will only be answered by upcoming clinical trials, such as whether the delivery approaches currently planned will be adequate to get the treatment to the necessary brain regions, and whether non-allele-selective huntingtin-lowering will be safe in the long run. Meantime, there is a role for preclinical research to address key knowledge gaps, including the effects of non-allele-selective huntingtin-lowering on protein trafficking and viability at the cellular level, the tolerability of wtHTT-lowering in the corticostriatal connections of the primate brain, and the effects of this lowering on the functioning of neurotransmitter systems and the transport of neurotrophic factors to the striatum

Experimental results and first 22Na source image reconstruction by two prototype modules in coincidence of a liquid xenon positron emission tomograph for small animal imaging

International audienceA detector with a very specific design using liquid Xenon (LXe) in the scintillation mode is studied for Positron Emission Tomography (PET) of small animals. Two prototype modules equipped with Position Sensitive Photo Multiplier Tubes (PSPMTs) operating in the VUV range (178 nm) and at 165 K were built and studied in coincidence. This paper reports on energy, time and spatial resolution capabilities of this experimental test bench. Furthermore, these experimental results were used to perform the first image reconstruction of a 22Na source placed in the experimental setup

A liquid Xenon Positron Emission Tomograph for small animal imaging : first experimental results of a prototype cell

A detector using liquid Xenon (LXe) in the scintillation mode is studied for Positron Emission Tomography (PET) of small animals. Its specific design aims at taking full advantage of the Liquid Xenon scintillation properties. This paper reports on energy, time and spatial resolution capabilities of the first LXe prototype module equipped with a Position Sensitive Photo- Multiplier tube (PSPMT) operating in the VUV range (178 nm) and at 165 K. The experimental results show that such a LXe PET configuration might be a promising solution insensitive to any parallax effect.Comment: 34 pages, 18 pages, to appear in NIM

Numerical Investigation of the Size Effects on the Creep Damage Coupling

AbstractThe service-life of concrete structures depends on the delayed strains that appear due to creep phenomenon. Few are the studies that treated the effect of the dimensions of concrete specimens on the amplitude and the kinetics of creep and the results show many contradictions. Thus, to design reliable civil engineering structures, the knowledge of the behaviour of concrete under a sustained load including size effect is necessary and performing calculations are needed. In this paper, the physical mechanisms behind the size effect on creep rate are evaluated at the mesoscopic scale. The material volume is modeled, by a Digital Concrete model which takes into account the microstructure heterogeneities and the “real” aggregate size of concrete. Calculations are performed in 2D by considering a viscoelastic damage behaviour law for the matrix and an elastic behavior for aggregates. The numerical results show that size effect is well reproduced by the meso-scale approach. The stresses under a sustained load are induced by strain incompatibilities between the components at the mesoscale. Accordingly, the evolution of the microcracked zone with the size of the bending specimens can be related to the creep rate